Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Mobile pränatale Aufklärung für werdende Väter und ihre Auswirkungen auf Bindung, Stress, Stillen und eheliche Zufriedenheit

2. Oktober 2026 aktualisiert von: Sebahat Kuşlu, Gaziantep Islam Science and Technology University

Mobile Pränatale Bildung für werdende Väter und ihre Auswirkungen auf Bindung, Stress, Stillen und eheliche Zufriedenheit

The aim of this interventional clinical trial is to assess whether a mobile-based antenatal education programme for expectant fathers has a positive effect on father-infant bonding, stress levels, and breastfeeding attitudes.

The study aims to answer the following main questions:

Does participation in a mobile-based prenatal education programme strengthen fathers' emotional bonds with their babies? Does the education reduce fathers' stress levels during the prenatal and postnatal periods? Does it increase the father's knowledge and supportive attitude towards breastfeeding? Researchers will compare whether there are measurable differences in attachment, stress, and breastfeeding attitudes between the intervention group (fathers receiving mobile-based education) and the control group (fathers receiving standard routine information).

Participants: Will complete pre- and post-intervention questionnaires assessing attachment, stress, and breastfeeding attitudes.

The intervention group will have access to a six-module mobile application covering topics such as infant care, nutrition, sleep routines, health and safety, emotional development, and daily care practices.

The study will be conducted with fathers aged 19-65 who became fathers within the last month and voluntarily agreed to participate.

Studienübersicht

Status

Noch keine Rekrutierung

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

This interventional clinical trial aims to evaluate the effectiveness of a mobile-based prenatal education programme designed specifically for expectant fathers. The programme aims to strengthen father-infant bonding, reduce paternal stress levels during the prenatal and early postnatal periods, and enhance fathers' knowledge and supportive attitudes related to breastfeeding.

The study is grounded in the increasing scientific evidence demonstrating that fathers play an important role in maternal-infant health, emotional bonding, family cohesion, and early childhood development. Despite this, fathers frequently receive limited antenatal education and often feel unprepared for infant care, breastfeeding support, and the psychological transition to fatherhood. Mobile health (mHealth) technologies provide accessible, cost-effective, and father-friendly educational opportunities that help reduce participation barriers.

In this trial, participants will be randomly assigned to either an intervention group or a control group. Fathers in the intervention group will have access to a six-module mobile application that offers structured prenatal education. The modules cover infant care, nutrition and feeding, sleep routines, health and safety practices, emotional and social development, and daily care skills. The educational content is designed to support cognitive, emotional, and behavioural readiness for fatherhood and to enhance fathers' confidence in newborn care.

Participants in both groups will complete pre- and post-intervention questionnaires assessing father-infant bonding, stress levels, and breastfeeding attitudes. The intervention group will complete the post-test after engaging with the mobile application, while the control group will receive routine standard information and complete the same assessments during the same time periods. Differences between the two groups will be analysed to determine whether the mobile-based education leads to significant improvements in psychological and behavioural outcomes.

The study will be conducted with fathers aged 19-65 who have become fathers within the past month and who voluntarily agree to participate. Exclusion criteria include lack of smartphone access, inability to use mobile applications, or unwillingness to complete the questionnaires.

This trial is expected to contribute to the development of evidence-based perinatal care interventions that enhance paternal involvement within the domain of women's health nursing, support family-centred care models, and promote practices that strengthen maternal and infant health.

Studientyp

Interventionell

Einschreibung (Geschätzt)

80

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studienorte

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

19 Jahre bis 65 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Männlich

Beschreibung

Inclusion Criteria:

  • Age between 19 and 65 years
  • First-time father
  • Has become a father within the last month
  • Has a healthy newborn without congenital anomalies or chronic illnesses
  • Does not have a premature or low-birth-weight baby
  • Has not become a father through adoption
  • Owns a mobile phone capable of accessing the mobile-based application
  • Has an Android or iOS operating system
  • Has not received any infant care training within the last 6 months
  • Has no physical or mental disability that would prevent viewing, hearing, or understanding the research questions or educational content
  • Voluntarily agrees to participate in the research

Exclusion Criteria:

  • Declines to participate in the research
  • Does not own a smartphone
  • Cannot use mobile applications
  • Has a physical or mental condition that prevents completing the questionnaires
  • Has a baby with congenital anomalies or chronic medical conditions
  • Has a premature or low-birth-weight baby
  • Has received infant care training within the last 6 months
  • Has adopted a child
  • Is outside the 19-65 age range

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Sonstiges
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Mobile-Based Prenatal Education for Expectant Fathers

Fathers in this arm will receive access to a six-module mobile-based prenatal education programme covering infant care, nutrition and feeding, sleep routines, health and safety practices, emotional and social development, and daily care skills. They will complete pre- and post-intervention questionnaires on father-infant bonding, stress levels, and breastfeeding attitudes.

The intervention is a six-module mobile-based training programme developed specifically for expectant fathers.

The modules cover baby care, nutrition, sleep patterns, health and safety, emotional development and daily care.

The aim is to strengthen the father-baby bond, reduce stress levels and develop a positive attitude towards breastfeeding.

Kein Eingriff: Standard Routine Information for Expectant Fathers

Fathers in this arm will receive standard routine information provided in usual care. They will not have access to the mobile-based education programme. They will complete the same pre- and post-intervention questionnaires on father-infant bonding, stress levels, and breastfeeding attitudes during the same time intervals as the intervention group.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Paternal Stress Levels
Zeitfenster: Baseline (Day 1) and Post-Intervention (8 weeks after baseline)

Paternal stress levels measured using the State-Trait Anxiety Inventory (STAI-State Subscale). A total score of 0-19 indicates no anxiety, a total score of 20-39 indicates mild anxiety, a total score of 40-59 indicates moderate anxiety, and a total score of 60-79 indicates severe anxiety. A total score of 60 or above indicates that the individual requires professional help.

Baseline (Day 1) and Post-Intervention (8 weeks after baseline)
Change in Father-Infant Bonding
Zeitfenster: Baseline (Day 1) and Post-Intervention (8 weeks after baseline)

Father-infant bonding measured using the Father-Infant Bonding Scale. High scores on the scale indicate a high level of attachment.

Baseline (Day 1) and Post-Intervention (8 weeks after baseline)
Change in Breastfeeding Attitudes and Participation
Zeitfenster: Baseline (Day 1) and Post-Intervention (8 weeks after baseline)

Fathers' attitudes and participation related to breastfeeding measured using the Fathers' Breastfeeding Attitude and Participation Scale. The total score under the sub-dimension of Fathers' Attitude Towards Breastfeeding ranges from 14 to 70, and the cut-off point for the scale is 58. The total score under the sub-dimension of Fathers' Participation in Breastfeeding ranges from 14 to 70, and the cut-off point for the scale is 58. High scores indicate high attitude and participation.

Baseline (Day 1) and Post-Intervention (8 weeks after baseline)
Change in Marital Satisfaction Levels
Zeitfenster: Baseline (Day 1) and Post-Intervention (8 weeks after baseline)

Marital satisfaction measured using the Marital Satisfaction Scale. The total score that can be obtained from the scale, which consists of a single subscale, ranges from 12 to 60 points. There are no reverse items on the scale. An increase in the score obtained from the scale indicates a high level of marital satisfaction.

Baseline (Day 1) and Post-Intervention (8 weeks after baseline)

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Ermittler

  • Hauptermittler: Sebahat Kuşlu, MSc, Gaziantep Islam Science and Technology University

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

1. Januar 2027

Primärer Abschluss (Geschätzt)

1. März 2027

Studienabschluss (Geschätzt)

1. April 2027

Studienanmeldedaten

Zuerst eingereicht

19. November 2025

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

16. Dezember 2025

Zuerst gepostet (Tatsächlich)

19. Dezember 2025

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

5. Oktober 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

2. Oktober 2026

Zuletzt verifiziert

1. Dezember 2025

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • Ethical Approval: 582.45.13

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

The ethics committee, confidentiality or national legislation deem sharing inappropriate.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .